Back to
BARCLAYS PLC
SKYE8 quarters
Position history for
BARCLAYS PLC's holdings in SKYE BIOSCIENCE INC
Yes. Barclays holds 655 shares of SKYE (Skye Bioscience), worth $455, as of its Q2 2026 13F filing. It reduced the position by 17,434 shares (-96.4%) from Q1 2026. Barclays has held SKYE since Q4 2025, across 3 quarterly 13F filings.
Current Value
$455
Current Shares
655
Total Value Change
-$338,673
Total Shares Change
-41,683
Quarter-by-Quarter History
Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., BAKER BROS. ADVISORS LP